Only 2 weeks to go until the 2024 ARCS Australia Annual Conference at the ICC, Sydney on 12-14 June. This year, the ARCS Annual Conference theme is “The Future of Medicine: The confluence of devices, drugs and data”, featuring a comprehensive program with parallel sessions spanning three days.
Our Director, Sarah Griffin is looking forward to attending the conference as well as Chairing SESSION B06 – The ABC’s of Regulatory and Reimbursement in the US Market Thursday 13 June at 11:15am. This session has 2 experts in US regulatory and reimbursement, Michelle Lott, Principal and Founder, leanRAQA and Nic Anderson Principal and Founder, N C Anderson Consulting.
It will include invaluable information for companies interested in exploring the complex US market.
- Where do you even begin as a medical device start-up for commercialisation in the US market – regulatory or reimbursement?
- For a start-up, regulatory and reimbursement are the foundation of a solid business plan.
Sarah added “As I frequently work with SME’s, I know the importance of getting local advice, so I am very excited to be chairing a session with two US experts, Michelle Lott and Nick Anderson who will discuss the basics of regulatory and reimbursement before entering the US market”.
